EFFECT OF AROMATASE INHIBITORS ON BONE MINERAL DENSITY IN PATIENTS WITH BREAST CANCER

被引：0
|
作者：
Khachidze, N. [1 ]
Giorgadze, E. [2 ]
Tsagareli, M. [3 ]
Dolidze, N. [2 ]
Sharikadze, N. [4 ]
Sulikashvili, T. [3 ]
Jeiranashvili, N. [3 ]
机构：
[1] Clin Curatio, Tbilisi, Georgia
[2] Natl Inst Endocrinol, Tbilisi, Georgia
[3] Natl Inst Endocrinol, Skeletal Endocrinol Unit, Tbilisi, Georgia
[4] Clin MediClub, Tbilisi, Georgia
来源：
OSTEOPOROSIS INTERNATIONAL | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P464
引用
收藏
页码：S237 / S238
页数：2
相关论文
共 50 条
  • [1] EFFECT OF AROMATASE INHIBITORS ON BONE MINERAL DENSITY AND TRABECULAR BONE MICROARCHITECTURE IN PATIENTS WITH BREAST CANCER
    Tsagareli, M.
    Giorgadze, E.
    Sulikashvili, T.
    Jeiranashvili, N.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S189 - S189
  • [2] Impact of adjuvant aromatase inhibitors on bone mineral density in breast cancer patients
    Lai, C. N.
    Correa, P. D.
    Alhasso, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Effect of Aromatase Inhibitors on Bone Mineral Density in a Japanese Breast Cancer Population
    Akiyoshi, Takeshi
    Shimomura, Yuka
    Masuda, Shinichi
    Okamoto, Yasushi
    Hiura, Sumiko
    Kato, Hiroyoshi
    Asayama, Toru
    Ohtani, Hisakazu
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (05) : 446 - 450
  • [4] Effects of Aromatase inhibitors on bone mineral density and trabecular bone score in patients with breast cancer
    Dabbagh, V.
    Shandiz, F. Homaee
    Kermani, A. Taghizadeh
    Javan, F. Nesari
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S465 - S465
  • [5] Bone mineral density in women with breast cancer and the impact of aromatase inhibitors
    Saleh, B.
    Gronland, N.
    Singer, J.
    Bradpiece, H.
    Patel, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : 384 - 385
  • [6] Denosumab effect on bone mineral density and urinary-NTX in breast cancer patients receiving aromatase inhibitors
    Masahiro Shibata
    Mai Okumura
    Shin Kawano
    Hirotoshi Noda
    Chihiro Toyota
    Yutaka Mizuno
    [J]. Journal of Bone and Mineral Metabolism, 2023, 41 : 567 - 574
  • [7] Denosumab effect on bone mineral density and urinary-NTX in breast cancer patients receiving aromatase inhibitors
    Shibata, Masahiro
    Okumura, Mai
    Kawano, Shin
    Noda, Hirotoshi
    Toyota, Chihiro
    Mizuno, Yutaka
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2023, 41 (04) : 567 - 574
  • [8] Bone mineral density screening and monitoring in early breast cancer patients treated with aromatase inhibitors
    Gilani, S.
    Ikram, N.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S227 - S227
  • [9] Bone Mineral Density Testing Disparities Among Patients With Breast Cancer Prescribed Aromatase Inhibitors
    Charlson, John
    Smith, Elizabeth C.
    Smallwood, Alicia J.
    Laud, Purushottam W.
    Neuner, Joan M.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (07): : 875 - 880
  • [10] Bone mineral density change on aromatase inhibitors as a predictor of breast cancer recurrence
    Martin, Hilary L.
    Davidson, John A.
    Yap, Francis
    Chung, Kim
    Khattak, Muhammad A.
    Redfern, Andrew D.
    [J]. CANCER RESEARCH, 2015, 75
12345